Damascus-SANA
Today, the Supreme Technical Committee for Medicine issued a decision to amend the prices of local medicines.
The Assistant Minister of Health for Pharmaceutical Affairs and Pharmaceutical Medicine, Obaidah Qatee’, explained in a statement to SANA that the Higher Technical Committee for Medicine includes a representative of the Scientific Council for Pharmaceutical Industries, the Syrian Pharmacists Syndicate and the Syrian Doctors Syndicate, in addition to representatives from the ministries of health, defense, higher education, economy, foreign trade and industry.
And about the decision between a herd that it aims to address the interruption that occurs in most of the locally manufactured pharmaceutical groups due to the high costs of their production and the increase in shipping fees for their imported raw materials, as a result of the economic siege and unilateral coercive measures imposed on the Syrian people, noting that the amendment was the only option to avoid drug interruption.
According to the deputy minister, some factory owners demanded an increase in drug prices by 100 percent, but the Higher Technical Committee for Medicine decided to increase it by 30 percent, in order to ensure the continuation of the production wheel in the national pharmaceutical laboratories at this stage, taking into account the economic conditions.
He stressed that the Ministry of Health will follow up, through its directorates and specialized oversight departments, the continuation of drug laboratories in producing them with the usual quality, and follow up their proper distribution.
The assistant minister added that the state still supports the national pharmaceutical industry through several measures, including exempting production requirements and raw materials involved in this industry from customs duties and all other taxes and fees imposed on import, in addition to the fact that the local pharmaceutical market is still protected for the benefit of local drug producers by not Allowing the import of pharmaceutical products that have more than one local factory, in order to motivate this industry to continue carrying out its national duty to secure effective and safe medicine for all patients of the country.
